SI2921168T1 - Sestavek n-(((7s)-3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-il)metil)-3-( 7,8-dimetoksi-1,2,4,5-tetrahidro-3h-3-benzazepin-3-il)-n-metil-3-okso-1- propanamina in perindoprila - Google Patents

Sestavek n-(((7s)-3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-il)metil)-3-( 7,8-dimetoksi-1,2,4,5-tetrahidro-3h-3-benzazepin-3-il)-n-metil-3-okso-1- propanamina in perindoprila

Info

Publication number
SI2921168T1
SI2921168T1 SI201130879A SI201130879A SI2921168T1 SI 2921168 T1 SI2921168 T1 SI 2921168T1 SI 201130879 A SI201130879 A SI 201130879A SI 201130879 A SI201130879 A SI 201130879A SI 2921168 T1 SI2921168 T1 SI 2921168T1
Authority
SI
Slovenia
Prior art keywords
methyl
dimethoxybicyclo
benzazepin
propanamine
trien
Prior art date
Application number
SI201130879A
Other languages
English (en)
Inventor
Christian Thuillez
Paulus Mulder
Jean-Paul Vilaine
Marie-Dominique Fratacci
Guy Lerebours-Pigeonniere
Luc Feldmann
Jerome Roussel
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42985210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2921168(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of SI2921168T1 publication Critical patent/SI2921168T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI201130879A 2010-06-15 2011-06-14 Sestavek n-(((7s)-3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-il)metil)-3-( 7,8-dimetoksi-1,2,4,5-tetrahidro-3h-3-benzazepin-3-il)-n-metil-3-okso-1- propanamina in perindoprila SI2921168T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1002525A FR2961105B1 (fr) 2010-06-15 2010-06-15 Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
EP15162899.7A EP2921168B1 (fr) 2010-06-15 2011-06-14 Association de la n-{[(7s)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-3-(7,8-dimethoxy-1,2,4,5-tetrahydro-3h-3-benzazepin-3-yl)-n-methyl-3-oxo-1-propanamine et du perindopril

Publications (1)

Publication Number Publication Date
SI2921168T1 true SI2921168T1 (sl) 2016-08-31

Family

ID=42985210

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201130568T SI2404600T1 (sl) 2010-06-15 2011-06-14 Uporaba kombinacije zaviralca lf toka sinusnega vozla in zaviralca angiotenzinske konvertaze za zdravljenje srčne insuficience z ohranjenim sistoličnim delovanjem
SI201130879A SI2921168T1 (sl) 2010-06-15 2011-06-14 Sestavek n-(((7s)-3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-il)metil)-3-( 7,8-dimetoksi-1,2,4,5-tetrahidro-3h-3-benzazepin-3-il)-n-metil-3-okso-1- propanamina in perindoprila

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI201130568T SI2404600T1 (sl) 2010-06-15 2011-06-14 Uporaba kombinacije zaviralca lf toka sinusnega vozla in zaviralca angiotenzinske konvertaze za zdravljenje srčne insuficience z ohranjenim sistoličnim delovanjem

Country Status (46)

Country Link
US (1) US20110306598A1 (sl)
EP (2) EP2404600B1 (sl)
JP (1) JP5480202B2 (sl)
KR (1) KR101389879B1 (sl)
CN (2) CN104906579A (sl)
AP (2) AP3691A (sl)
AR (1) AR081875A1 (sl)
AU (1) AU2011202607B2 (sl)
BR (1) BRPI1102830F1 (sl)
CA (1) CA2743527C (sl)
CL (1) CL2011001420A1 (sl)
CO (1) CO6640265A2 (sl)
CR (1) CR20120609U (sl)
CU (1) CU24161B1 (sl)
CY (2) CY1116438T1 (sl)
DK (2) DK2404600T3 (sl)
EA (1) EA022612B1 (sl)
EC (1) ECSP12012337A (sl)
ES (2) ES2582157T3 (sl)
FR (1) FR2961105B1 (sl)
GE (1) GEP20146132B (sl)
GT (1) GT201200341A (sl)
HK (2) HK1210011A1 (sl)
HR (2) HRP20150745T1 (sl)
HU (2) HUE027788T2 (sl)
IL (1) IL223293A (sl)
JO (1) JO3309B1 (sl)
MA (1) MA33235B1 (sl)
ME (2) ME02476B (sl)
MX (1) MX2011006001A (sl)
MY (1) MY179034A (sl)
NI (1) NI201200182A (sl)
NZ (2) NZ593437A (sl)
PE (1) PE20120019A1 (sl)
PL (2) PL2921168T3 (sl)
PT (1) PT2404600E (sl)
RS (2) RS54077B1 (sl)
SA (2) SA114360089B1 (sl)
SG (2) SG177069A1 (sl)
SI (2) SI2404600T1 (sl)
TN (1) TN2012000551A1 (sl)
TW (1) TWI468164B (sl)
UA (1) UA108983C2 (sl)
UY (1) UY33423A (sl)
WO (1) WO2011157908A1 (sl)
ZA (1) ZA201104222B (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603666A (zh) * 2012-02-28 2012-07-25 石河子大学 肉桂酰牛磺酰噻唑烷酸类化合物及其应用
FR3020810B1 (fr) * 2014-05-06 2016-05-06 Servier Lab Nouveau sel de l'ivabradine et son procede de preparation.
EP3025705B8 (en) * 2014-11-25 2018-11-28 Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi Stable ivabradine formulations
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법
CN107550915A (zh) * 2017-10-31 2018-01-09 泰州中国医药城中医药研究院 一种伊伐布雷定和咯利普兰组合物及其在制药中的应用
CN107714702A (zh) * 2017-10-31 2018-02-23 泰州中国医药城中医药研究院 一种伊伐布雷定和米力农组合物及其在制药中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US6188743B1 (en) * 1997-10-10 2001-02-13 Analogic Corporation Computed tomography scanner drive system and bearing
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
SI1362590T1 (sl) * 2002-07-25 2004-04-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje
AU2005294318A1 (en) * 2004-10-08 2006-04-20 Novartis Ag Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
WO2007014051A2 (en) * 2005-07-22 2007-02-01 Amylin Pharmaceuticals, Inc. Use of amylin and amylin agonists as cardioprotective or myoprotective agents
FR2891826B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2911279B1 (fr) * 2007-01-11 2009-03-06 Servier Lab Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2921365B1 (fr) * 2007-09-21 2012-10-12 Servier Lab Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
RU2364401C1 (ru) * 2008-05-12 2009-08-20 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" Способ коррекции сосудистого ремоделирования у больных хронической сердечной недостаточностью ишемической этиологии
WO2009158005A1 (en) * 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Benzazepinone compounds
RU2382644C1 (ru) * 2008-11-05 2010-02-27 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" Способ коррекции гипертрофии левого желудочка у больных ибс в сочетании с гипертонической болезнью

Also Published As

Publication number Publication date
GEP20146132B (en) 2014-08-11
AU2011202607A1 (en) 2012-01-12
AU2011202607B2 (en) 2015-02-12
ME02476B (me) 2017-02-20
JP2012001545A (ja) 2012-01-05
FR2961105A1 (fr) 2011-12-16
ME02163B (me) 2015-10-20
SG10201500502WA (en) 2015-03-30
AP2013006661A0 (en) 2013-01-31
HK1210011A1 (zh) 2016-04-15
AP2016009002A0 (en) 2016-01-31
SA111320527B1 (ar) 2015-03-19
CO6640265A2 (es) 2013-03-22
AR081875A1 (es) 2012-10-24
US20110306598A1 (en) 2011-12-15
BRPI1102830B1 (pt) 2019-10-08
EP2404600A1 (fr) 2012-01-11
PE20120019A1 (es) 2012-02-11
NI201200182A (es) 2013-05-13
JO3309B1 (ar) 2018-09-16
AP3691A (en) 2016-04-30
WO2011157908A8 (fr) 2013-01-17
UY33423A (es) 2011-12-30
ES2582157T3 (es) 2016-09-09
ES2545343T3 (es) 2015-09-10
TWI468164B (zh) 2015-01-11
PT2404600E (pt) 2015-07-13
IL223293A0 (en) 2013-02-03
RS54077B1 (en) 2015-10-30
CA2743527C (fr) 2016-08-02
CU20120166A7 (es) 2013-04-19
SA114360089B1 (ar) 2016-02-03
SI2404600T1 (sl) 2015-10-30
TN2012000551A1 (fr) 2014-04-01
WO2011157908A1 (fr) 2011-12-22
NZ600931A (en) 2013-04-26
MA33235B1 (fr) 2012-05-02
CR20120609U (es) 2013-02-05
CY1117724T1 (el) 2017-05-17
EP2404600B1 (fr) 2015-05-27
HUE027788T2 (en) 2016-10-28
MX2011006001A (es) 2011-12-14
EP2921168B1 (fr) 2016-04-13
HUE027088T2 (en) 2016-08-29
CY1116438T1 (el) 2017-02-08
CN104906579A (zh) 2015-09-16
EP2921168A1 (fr) 2015-09-23
EA022612B1 (ru) 2016-02-29
DK2921168T3 (en) 2016-08-01
PL2921168T3 (pl) 2016-10-31
KR101389879B1 (ko) 2014-04-29
HK1210012A1 (en) 2016-04-15
NZ593437A (en) 2012-08-31
CU24161B1 (es) 2016-03-31
SG177069A1 (en) 2012-01-30
RS54838B1 (sr) 2016-10-31
ECSP12012337A (es) 2012-12-28
KR20110136752A (ko) 2011-12-21
TW201206445A (en) 2012-02-16
IL223293A (en) 2017-04-30
UA108983C2 (en) 2015-07-10
JP5480202B2 (ja) 2014-04-23
MY179034A (en) 2020-10-26
EA201100773A1 (ru) 2011-12-30
PL2404600T3 (pl) 2015-10-30
GT201200341A (es) 2014-03-14
HRP20150745T1 (hr) 2015-08-14
BRPI1102830F1 (pt) 2022-03-29
CL2011001420A1 (es) 2012-07-06
FR2961105B1 (fr) 2013-02-08
CA2743527A1 (fr) 2011-12-15
ZA201104222B (en) 2012-02-29
HRP20160643T1 (hr) 2016-07-01
BRPI1102830B8 (pt) 2020-01-07
BRPI1102830A2 (pt) 2013-12-24
CN102284060A (zh) 2011-12-21
DK2404600T3 (en) 2015-08-31

Similar Documents

Publication Publication Date Title
HK1210011A1 (zh) -{ }- -{ -二甲氧二環 辛- -三烯- -基 甲基}- -二甲氧基- -四氫- -苯並氮雜䓬- -基 -甲基- -氧代- -丙胺和培哚普利的組合
MX2010002974A (es) Formas solidas de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4- dihidro-4-oxoquinolin-3-carboxamida.
HK1257458A1 (zh) 來自nephilengys cruentata蜘蛛、黃帶粉趾食鳥蛛和parawixia bistriata蜘蛛的網的蛋白
EP1993360A4 (en) SOLID FORMS OF N- [2,4-BIS (1,1-DIMETHYLETHYL) -5-HYDROXYPHENYL] -1,4-DIHYDRO-4-OXOCHINOLINE-3-CARBOXAMIDE
AP2006003762A0 (en) D-crystalline form of ivabradine hydro chloride, aprocess for its preparation and pharmaceutical c ompositions containing it
PL2166004T3 (pl) Nowy sposób rozdzielania enancjomerów (3,4-dimetoksy-bicyklo[4.2.0]okta -1,3,5-trien -7-ylo)nitrylu i ich zastosowanie do syntezy iwabradyny
HK1140188A1 (en) New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin- 2-one, and application thereof
EP2606139A4 (en) BIOCATALYSTS AND METHODS FOR SYNTHESIZING (1R, 2R) -2- (3,4-DIMETHOXYPHENYL ETHYL) CYCLOHEXANAMINE
UA103996C2 (en) Ivabradine hydrobromide
IL215103A0 (en) N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME
GEP20135970B (en) New method of synthesis of ivabradine and pharmaceutically acceptable acid-additive salts thereof
EA201300719A2 (ru) Способ ферментативного синтеза (7s)-1-(3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил) n-метилметанамина и применение в синтезе ивабрадина и его солей
PL2626428T3 (pl) Sposób syntezy enzymatycznej kwasu (7S)-3,4-dimetoksybicyklo[4.2.0]okta-1,3,5-trien-7-karboksylowego lub jego estrów i zastosowania do syntezy iwabradyny i jej soli
IL202766A (en) Opioid Pharmacist and Prostaglandin Composition, a commercial kit that includes its use and uses
EP1931324A4 (en) Α-C, D ANALOGUES OF 1ALPHA, 25-DIHYDROXY-19-NORVITAMIN D3
HRP20150950T1 (en) Method for enzymatic synthesis of (7s)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid, and use for the synthesis of ivabradine and the salts thereof
IL212749A0 (en) Novel forms of an indazolo [5,4-a] carbazole compound
TH137164B (th) การใช้ประโยชน์จากการร่วมกันของสารยับยั้งกระแสไซนัสโหนด If (sinus node If current inhibitor)และสารยับยั้งเอนไซม์ซึ่งเปลี่ยนผันแองจิโอเทนซิน(angiotensin-converting enzyme inhibitor)ในการบำบัดภาวะหัวใจล้มเหลว
ZA201108112B (en) Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
AU2008906368A0 (en) Textu're Message
IL214490A0 (en) N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
TH137164A (th) การใช้ประโยชน์จากการร่วมกันของสารยับยั้งกระแสไซนัสโหนด If (sinus node If current inhibitor) และสารยับยั้งเอนไซม์ซึ่งเปลี่ยนผันแองจิโอเทนซิน (angiotensin-converting enzyme inhibitor) ในการบำบัดภาวะหัวใจล้มเหลว
PL384052A1 (pl) Nowe pochodne N-[1,3-diokso-3a,4,5,6,7,7a-heksahydro-1H-izoindo-2(3H)-ylo]-N-arylobenzimidoamidu oraz sposób ich wytwarzania
PL387384A1 (pl) Nowy związek 2-hydroksy-4-metylo-9-oksabicyklo [4.3.0] nonan-8-on i sposób jego otrzymywania